Connective Tissue Diseases clinical trials

Explore recruiting connective tissue diseases clinical trials.

Recruiting connective tissue diseases studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Connective Tissue Diseases trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open-label study to investigate the long-term safety and efficacy of belimumab in adults with interstitial lung disease (ILD) associated with systemic sclerosis (SSc) and other connective tissue diseases (CTD)

Greece, Denmark, Italy, Finland, Spain, France +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Early recognition of progressive lung fibrosis in systemic rheumatic diseases: a characterization of the pulmonary environment through extracellular vesicles, advanced and functional imaging

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

J1A-MC-KDAF: A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Peresolimab in Adult Participants with Moderately-to-Severely Active Rheumatoid Arthritis

Hungary, Spain, Italy, Poland, Greece

Therapeutic exploratory (Phase II) EU CTIS Study details

Treatment of frontal fibrosing alopecia with microneedling and photodynamic therapy using 5-aminolevulinic acid in male and female adult participants – an open single group phase 2 study

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Prospective Randomised Nordic Frostbite Treatment Study comparing tPA and iloprost therapy

Finland

Therapeutic use (Phase IV) EU CTIS Study details

A phase 2, randomised, double-blind, vehicle-controlled, dose finding, efficacy, tolerability and safety study of Victorhy in patients with severe hand hyperhidrosis

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Connective Tissue Diseases trials by city

Connective Tissue Diseases clinical trials

Recruiting connective tissue diseases studies right now

A Study of AZD0120 in Autoimmune Diseases

CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases

Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ

Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

ZYG24002 Lotion to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Adult Patients With Mild to Moderate Seborrheic Dermatitis

A Study of MR001 in Patients With Locally Recurrent or Metastatic Advanced Triple-Negative Breast Cancer (TNBC)

Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)

1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia

FAST-FORWARD vs HAI5

Preoperative Radiation Therapy and Immediate Breast Reconstruction

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Also recruiting in Europe

An open-label study to investigate the long-term safety and efficacy of belimumab in adults with interstitial lung disease (ILD) associated with systemic sclerosis (SSc) and other connective tissue diseases (CTD)

Early recognition of progressive lung fibrosis in systemic rheumatic diseases: a characterization of the pulmonary environment through extracellular vesicles, advanced and functional imaging

J1A-MC-KDAF: A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Peresolimab in Adult Participants with Moderately-to-Severely Active Rheumatoid Arthritis

Treatment of frontal fibrosing alopecia with microneedling and photodynamic therapy using 5-aminolevulinic acid in male and female adult participants – an open single group phase 2 study

Prospective Randomised Nordic Frostbite Treatment Study comparing tPA and iloprost therapy

A phase 2, randomised, double-blind, vehicle-controlled, dose finding, efficacy, tolerability and safety study of Victorhy in patients with severe hand hyperhidrosis

Connective Tissue Diseases trials by city

Other conditions